Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: Findings from the 2006-2008 National Survey of Family Growth

Vaccine

Volumn 30, Issue 16, 2012, Pages 2676-2682

  Liddon, Nicole C ^a   Hood, Julia E ^a   Leichliter, Jami S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Human papillomavirus vaccine; National survey of family growth; Vaccine coverage

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEALTH BELIEF; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HISPANIC; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; SEXUAL BEHAVIOR; TREATMENT REFUSAL; VACCINATION;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ANALYSIS OF VARIANCE; DATA COLLECTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISPANIC AMERICANS; HUMANS; INSURANCE, HEALTH; LONGITUDINAL STUDIES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; SEXUAL BEHAVIOR; UNITED STATES; VACCINATION;

EID: 84858275905     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.02.007     Document Type: Article

References (24)

1. Cogliano V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol 2005, 6(April (4)):204.
2. Markowitz L.E., Sternberg M., Dunne E.F., McQuillan G., Unger E.R. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis 2009, 200(October (7)):1059-1067.
3. CDC FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010, 59(May (20)):626-629.
4. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(March (RR-2)):1-24.
5. CDC National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59(August (32)):1018-1023.
6. CDC Vaccination coverage among adolescents aged 13-17 years-United States, 2007. MMWR Morb Mortal Wkly Rep 2008, 57(October (40)):1100-1103.
7. CDC National and state vaccination coverage among adolescents aged 13 through 17 years-United States, 2010. MMWR Morb Mortal Wkly Rep 2011, 60(August (33)):1117-1123.
8. Dickerson J.B., Smith M.L., Ory M.G. Increasing uptake of Gardasil among American adolescents: comparisons with the history of Hepatitis B vaccination. Hum Vaccine 2011, 7(February (2)).
9. Bednarczyk R.A., Birkhead G.S., Morse D.L., Doleyres H., McNutt L.A. Human papillomavirus vaccine uptake and barriers: Association with perceived risk, actual risk and race/ethnicity among female students at a New York State university. Vaccine 2010, March (2).
10. Bendik M.K., Mayo R.M., Parker V.G. Knowledge, perceptions, and motivations related to HPV vaccination among college women. J Cancer Educ 2011, 21.
11. Caskey R., Lindau S.T., Alexander G.C. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 2009, 45(November (5)):453-462.
12. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010, 171(February (3)):357-367.
13. Conroy K., Rosenthal S.L., Zimet G.D., et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt) 2009, 18(October (10)):1679-1686.
14. Cook R.L., Zhang J., Mullins J., et al. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health 2010, 47(December (6)):596-599.
15. Dempsey A., Cohn L., Dalton V., Ruffin M. Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine 2011, 29(January (3)):528-534.
16. Jain N., Euler G.L., Shefer A., Lu P., Yankey D., Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States. National Immunization Survey-Adult 2007. Prev Med 2009, 48(May (5)):426-431.
17. Licht A.S., Murphy J.M., Hyland A.J., Fix B.V., Hawk L.W., Mahoney M.C. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?. Sex Transm Infect 2010, 86(February (1)):74-78.
18. Roberts M.E., Gerrard M., Reimer R., Gibbons F.X. Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics 2010, 125(May (5)):982-989.
19. Lepkowski JM, Mosher W, Davis KE, Groves RM, Van Hoewyk J. The 2006-2010 National Survey of Family Growth: sample design and analysis of a continuous survey. National Center for Health Statistics. Vital Health Stat 2(150); 2010. Available at http://www.cdc.gov/nchs/data/series/sr_02/sr02_150.pdf.
20. Liddon N.C., Leichliter J.S., Markowitz L.E. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med 2012, 42(1):44-52.
21. McKee M.D., Fletcher J., Schechter C.B. Predictors of timely initiation of gynecologic care among urban adolescent girls. J Adolesc Health 2006, 39(August (2)):183-191.
22. Dorell C., Yankey D., Strasser S. Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, National Immunization Survey-Teen, 2009. Clin Pediatr 2011, 1-9.
23. Guerry S.L., De Rosa C.J., Markowitz L.E., et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine 2011, 29(March (12)):2235-2241.
24. Rosenthal S.L., Weiss T.W., Zimet G.D., Ma L., Good M.B., Vichnin M.D. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2011, 29(January (5)):890-895.